GENE ONLINE|News &
Opinion
Blog

2017-11-06|

November 6, 1946: Celebrate the Birthday of American Genetictist Douglas C. Wallace

by GeneOnline
Share To

Douglas Cecil Wallace (November 6, 1946 – present) is an American geneticist known for his study in mitochondrial DNA. In 1975, Wallace and the other associate researchers proved for the first time that mutations on mitochondrial DNA region are related to genetic disorders. Later in 1990 he described a mitochondrial DNA mutation as the cause of a specific form of myoclonic epilepsy, and the discovery swiftly raised the attention in medicine and academia. Wallance was the first scientist to use human mitochondrial DNA as a molecular marker, and has greatly contributed to the study of the mitochondrial genome in evolution, DNA paternity testing, historical research, and genetic medicine.

Reference

https://en.wikipedia.org/wiki/Douglas_C._Wallace

Image Source

https://en.wikipedia.org/wiki/Douglas_C._Wallace

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
R&D
New Mitochondrial Response Pathway May Advance Treatments for Inflammatory Diseases
2022-07-14
R&D
Massive Human CRISPR-Based Genotype-Phenotype Map Is Now Complete
2022-06-13
R&D
Phenomix Launches The First Obesity Biobank Registry To Study Underling Phenotypes
2022-05-26
LATEST
Novartis’ CDK4/6 Inhibitor Meets Phase 3 Endpoints In Breast Cancer
2023-03-28
BD and A*STAR collaborate to Advance Ultra-High Dimensional Analysis in Flow Cytometry for Immunology Research
2023-03-28
Vertex and CRISPR Collaborate Again with $330 Million Diabetes Gene Editing Deal
2023-03-28
Amway Applauded by Frost & Sullivan for Capitalizing on Innovative Competitive Strategies to Drive Differentiation in Its Home Water Treatment Solution in APAC
2023-03-28
BJ Bioscience Announces Clinical Collaboration with MSD to Evaluate BJ-001 in Combination with KEYTRUDA® (pembrolizumab)
2023-03-27
35% Of Better Therapeutics’ Staff to be Cut to Extend the Company’s Runway
2023-03-27
Pharming’s Joenja Racks Up FDA Approval For Rare Primary Immunodeficiency
2023-03-27
Scroll to Top